MXPA02011531A - Beneficio de superviviencia. - Google Patents
Beneficio de superviviencia.Info
- Publication number
- MXPA02011531A MXPA02011531A MXPA02011531A MXPA02011531A MXPA02011531A MX PA02011531 A MXPA02011531 A MX PA02011531A MX PA02011531 A MXPA02011531 A MX PA02011531A MX PA02011531 A MXPA02011531 A MX PA02011531A MX PA02011531 A MXPA02011531 A MX PA02011531A
- Authority
- MX
- Mexico
- Prior art keywords
- survival
- water
- pharmaceutical compositions
- metal ion
- propofol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0012599A GB0012599D0 (en) | 2000-05-25 | 2000-05-25 | Survival benefit |
GB0013367A GB0013367D0 (en) | 2000-06-02 | 2000-06-02 | Survival benefit |
PCT/GB2001/002267 WO2001089514A2 (en) | 2000-05-25 | 2001-05-22 | Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02011531A true MXPA02011531A (es) | 2003-04-25 |
Family
ID=26244338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02011531A MXPA02011531A (es) | 2000-05-25 | 2001-05-22 | Beneficio de superviviencia. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1289518A2 (ko) |
JP (1) | JP2003534277A (ko) |
KR (1) | KR20030007686A (ko) |
CN (1) | CN1217657C (ko) |
AU (1) | AU2001258592A1 (ko) |
BR (1) | BR0111094A (ko) |
CA (1) | CA2408033A1 (ko) |
IL (1) | IL152774A0 (ko) |
MX (1) | MXPA02011531A (ko) |
NO (1) | NO20025628L (ko) |
WO (1) | WO2001089514A2 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2470500C (en) * | 2001-12-28 | 2012-05-15 | Guilford Pharmaceuticals, Inc. | Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
BR0313060A (pt) | 2002-07-29 | 2005-06-28 | Transform Pharmaceuticals Inc | Composições farmacêuticas aquosas de 2,6-diisopropilfenol |
US7550155B2 (en) | 2002-07-29 | 2009-06-23 | Transform Pharmaceuticals Inc. | Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9405593D0 (en) * | 1994-03-22 | 1994-05-11 | Zeneca Ltd | Pharmaceutical compositions |
US6140374A (en) * | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
-
2001
- 2001-05-22 IL IL15277401A patent/IL152774A0/xx unknown
- 2001-05-22 MX MXPA02011531A patent/MXPA02011531A/es unknown
- 2001-05-22 JP JP2001585758A patent/JP2003534277A/ja active Pending
- 2001-05-22 KR KR1020027015890A patent/KR20030007686A/ko not_active Application Discontinuation
- 2001-05-22 WO PCT/GB2001/002267 patent/WO2001089514A2/en not_active Application Discontinuation
- 2001-05-22 AU AU2001258592A patent/AU2001258592A1/en not_active Abandoned
- 2001-05-22 BR BR0111094-2A patent/BR0111094A/pt not_active IP Right Cessation
- 2001-05-22 CN CN018101011A patent/CN1217657C/zh not_active Expired - Fee Related
- 2001-05-22 CA CA002408033A patent/CA2408033A1/en not_active Abandoned
- 2001-05-22 EP EP01931901A patent/EP1289518A2/en not_active Ceased
-
2002
- 2002-11-22 NO NO20025628A patent/NO20025628L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2001089514A2 (en) | 2001-11-29 |
CN1430511A (zh) | 2003-07-16 |
IL152774A0 (en) | 2003-06-24 |
NO20025628D0 (no) | 2002-11-22 |
CA2408033A1 (en) | 2001-11-29 |
EP1289518A2 (en) | 2003-03-12 |
NO20025628L (no) | 2003-01-16 |
JP2003534277A (ja) | 2003-11-18 |
BR0111094A (pt) | 2003-04-08 |
AU2001258592A1 (en) | 2001-12-03 |
KR20030007686A (ko) | 2003-01-23 |
CN1217657C (zh) | 2005-09-07 |
WO2001089514A3 (en) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60129134D1 (en) | O/w emulsion | |
NZ513810A (en) | Compositions and methods for improved delivery of hydrophobic therapeutic agents | |
BR0111196A (pt) | Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus | |
GT200100039A (es) | Inhibidor de la glucogeno fosforilasa. | |
BR0309138A (pt) | Processo para a preparação de uma composição farmacêutica finamente auto-emulsionável | |
BR0212163A (pt) | Composição para tratamento ou prevenção de infecção em plantas | |
AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
EA200001043A2 (ru) | Соединения для лечения женской сексуальной дисфункции | |
BR0213040A (pt) | Composto, processo para preparar um composto, e, método de tratar doenças | |
SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
HK1028879A1 (en) | Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation | |
CA2376916A1 (en) | Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist | |
MXPA02012611A (es) | Composicion anestesica, acuosa, clara. | |
MXPA02011531A (es) | Beneficio de superviviencia. | |
BRPI0409413A (pt) | composição farmacêutica, uso de um ácido ou sal biliar não conjugado, e, métodos para intensificar a absorção de um princìpio macromolecular ativo em um pacinete e para tratar um paciente que esteja sofrendo de uma condição ou doença tratável | |
MY126117A (en) | Pharmaceutical compositions | |
BR0009214A (pt) | Composições aquosas estáveis contendo umcomposto de silìcio | |
MY140556A (en) | Clear pharmaceutical aqueous microemulsion comprising propofol and process for preparation | |
BR0116290A (pt) | Processo para a obtenção de ácido (met) acrìlico na presença de pelo menos um estabilizador | |
GB2412066A (en) | Method of reducing toxicity of anticancer agents | |
BR9908838A (pt) | Uso de um glicocorticóide, processeo para tratar glomerulonefrite aguda ou crÈnica, e, composição farmacêutica para tratar glomerulonefrite | |
EA200801973A1 (ru) | Перфторуглеродная газопереносящая эмульсия для медико-биологических целей, способ ее получения и средство для лечения (варианты) | |
SE0002354D0 (sv) | New formulation | |
BR0316123A (pt) | Formulação farmacêutica aquosa, uso de uma formulação farmacêutica aquosa, e, método de tratamento de um paciente com necessidade de tratamento antitrombótico | |
MX9708160A (es) | Composicion y aparato para la limpieza de superficies. |